Close Menu

The Scan

GMO plants will use RNAi to kill pests.

Why Not Use Both?

Baylor pairs next-gen sequencing with microarrays with for resequencing.

For the Lab On the Go

Blogger Deepak Singh wonders if scientists would ever be ready for labs powered by mobile devices rather than personal computers.

NIH studies why women leave scientific research.

Science covers glycobiology, Linnaeus, and the circadian clock in this week's issue.

Phil Green points out the flaws of continuing to assemble 2x sequences.

Open access is defined -- again.

George Church sells the $1,000 genome.

Members of the US House and Senate meet today to finalize the 2008 Department of Health and Human Services appropriations bill.

Keith Robison blogs about "Easter Eggs."

This week in Nature, there's the Autism Consortium, oomycete effector proteins, mouse spermatogenesis, and more.

Cinnamon's Genome

The genome of an Abyssinian cat is published.

Doctors don't always know what to do when a newborn is thought to have a rare genetic disease.

A blogger's take on British Telecom's thought for the future of biopharma.

Back for More

Craig Venter returns to the Colbert Report.

Advice to science grad students: it's hard work.

Theoretical chemist Leslie Orgel dies from pancreatic cancer.

Francis S. Collins is awarded the Presidential Medal of Freedom.

A blogger explains peer review to the industry crowd.

A new book explores evil genes.

Steven Salzberg wonders if "conservative" means "anti-knowledge."

PLoS Computational Biology launches a new series of articles.

Jonathan Eisen lists what he likes about Cold Spring Harbor.

VC biotech funding is decreasing.

"Watson's Folly" is a warning, says Seven Stones blogger.

Pages

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.